ProCaRe – ProCaRe Issue 2
Galway Clinic hosts the Inaugural Irish Robotic Prostatectomy Symposium
This meeting concentrated on the use of robotic surgery and the da Vinci robot in the treatment of prostate cancer.
Dr. Bernardo Rocco, Milan
This meeting concentrated on the use of robotic surgery and the da Vinci robot in the treatment of prostate cancer, a method of treatment which is now becoming the most common surgical approach to removal of the prostate for prostate cancer in many parts of the world.
The faculty featured many of the world key opinion leaders in robotic surgery and urology. There were robotic surgeons from Seattle, Washington; University of California, Irvine; the Mayo Clinic, Arizona; the Royal Melbourne hospital and Peter MacCallum Cancer Institute, Melbourne, Australia; Guy’s and St Thomas’s Hospital, London as well as surgeons from Milan, Italy, Dublin and Galway who assembled together as one of the most high-calibre faculties seen at an Irish urology meeting in many years.
Technical aspects employed in robotic surgery was presented by Mr. David Bouchier-Hayes of the Galway clinic. Following this, Mr. Paddy O’Malley, also the Galway Clinic, presented the data of the first consecutive 125 robotic radical prostatectomies performed in the Galway Clinic. These results were acknowledged by the international faculty members as being especially strong and Mr. O’Malley, Mr. Bouchier Hayes and the rest of their team were complimented on their outstanding work to date.
The conclusion after much debate was that robotics and new technology is here to stay and needs to be embraced, but that cost still remains a significant issue. Prof John Fitzpatrick from the Mater Misericordiae Hospital in Dublin spoke with great authority on how scientific publication in the field of robotic surgery can and must be improved, speaking from his unique position as editor of the British Journal of Urology International.
Other presentations included Dr. Gregory Leonard, consultant medical oncologist in Galway, who spoke about new perspectives on chemotherapy in hormone resistant prostate cancer. Prof Erik Castle, of the Mayo Clinic, Arizona, then discussed the use of the da Vinci robotic system in the treatment of renal cell and transitional cell cancer of the upper renal tract/kidney. Mr. Declan Cahill, of Guys and St. Thomas’s Hospital, discussed his own personal transition from laparoscopic radical prostatectomy to robotic assisted radical prostatectomy and his reasons for preferring robotic surgery over straightforward laparoscopic surgery. Prof Castle then discussed the increasing use of the da Vinci robotic system for the surgical treatment of bladder cancer in the United States.
Mr. Kiaran O’Malley presented on his own transition from open radical prostatectomy to robotic radical prostatectomy and the outstanding results from his programme in the Mater Private hospital, the second robotic prostatectomy centre established in Ireland. Prof Anthony Costello, one of the world opinion leaders in robotic prostatectomy, from the Royal Melbourne Hospital, Australia then discussed techniques for improving return of potency following robotic prostate surgery.